ARCTURUS THERAPEUTICS HOLDINGS INC. Increase (Decrease) in Accounts Payable
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Increase (Decrease) in Accounts Payable of $179.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $321.00K, a 92.78% decline year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$142.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.34M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$5.04M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for fiscal 2025 was -$2.96M, a 254.52% decline from fiscal 2024.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for fiscal 2024 was $1.92M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for fiscal 2023 was -$2.24M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in accounts payable for fiscal 2022 was -$3.11M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $179.00K 10-Q · filed 2026-08-06 | -$1.16M derived: sum of 3 quarters · filed 2026-08-06 | -$6.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$142.00K 10-Q · filed 2026-05-07 | -$1.49M derived: sum of 2 quarters · filed 2026-05-07 | -$6.53M derived: sum of 3 quarters · filed 2026-05-07 | -$2.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$6.39M derived: sum of 2 quarters · filed 2026-03-03 | -$1.94M derived: sum of 3 quarters · filed 2026-08-06 | -$2.96M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$5.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$601.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.62M 10-Q · filed 2025-11-12 | -$4.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.43M 10-Q · filed 2026-08-06 | $492.00K derived: sum of 3 quarters · filed 2026-08-06 | -$3.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.01M 10-Q · filed 2026-05-07 | -$3.95M derived: sum of 2 quarters · filed 2026-05-07 | -$7.73M derived: sum of 3 quarters · filed 2026-05-07 | -$2.96M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$6.71M derived: sum of 2 quarters · filed 2026-03-03 | -$1.95M derived: sum of 3 quarters · filed 2026-03-03 | $1.92M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $987.00K derived: sum of 2 quarters · filed 2025-11-12 | $4.85M 10-Q · filed 2025-11-12 | -$7.88M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $8.63M 10-Q · filed 2025-08-11 | -$4.11M derived: sum of 3 quarters · filed 2026-03-03 | $795.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $3.87M 10-Q · filed 2025-05-12 | -$8.87M derived: sum of 2 quarters · filed 2026-03-03 | -$3.97M derived: sum of 3 quarters · filed 2026-03-03 | -$10.16M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$12.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$7.83M derived: sum of 2 quarters · filed 2026-03-03 | -$14.03M derived: sum of 3 quarters · filed 2026-03-03 | -$2.24M 10-K · filed 2026-03-03 |
| 2023-09-30 | $4.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.29M derived: sum of 2 quarters · filed 2024-11-07 | $10.50M 10-Q · filed 2024-11-07 | $2.05M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | -$6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $5.59M 10-Q · filed 2024-08-05 | -$2.85M derived: sum of 3 quarters · filed 2025-03-06 | $6.90M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $11.79M 10-Q · filed 2024-05-08 | $3.34M derived: sum of 2 quarters · filed 2025-03-06 | $13.10M derived: sum of 3 quarters · filed 2025-03-06 | $8.72M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | -$8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.31M derived: sum of 2 quarters · filed 2025-03-06 | -$3.07M derived: sum of 3 quarters · filed 2025-03-06 | -$3.11M 10-K · filed 2025-03-06 |
| 2022-09-30 | $9.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $5.38M derived: sum of 2 quarters · filed 2023-11-14 | $5.33M 10-Q · filed 2023-11-14 | $7.13M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$4.42M 10-Q · filed 2023-08-07 | -$2.62M derived: sum of 3 quarters · filed 2024-03-14 | -$4.40M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$44.00K 10-Q · filed 2023-05-09 | $1.76M derived: sum of 2 quarters · filed 2024-03-14 | -$22.00K derived: sum of 3 quarters · filed 2024-03-14 | $4.60M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $22.00K derived: sum of 2 quarters · filed 2024-03-14 | $4.65M derived: sum of 3 quarters · filed 2024-03-14 | -$769.00K 10-K · filed 2024-03-14 |
| 2021-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.85M derived: sum of 2 quarters · filed 2022-11-09 | -$2.57M 10-Q · filed 2022-11-09 | $2.23M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$791.00K 10-Q · filed 2022-08-09 | $4.01M derived: sum of 3 quarters · filed 2022-08-09 | $5.46M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$5.42M 10-Q · filed 2022-05-09 | -$618.00K derived: sum of 2 quarters · filed 2022-05-09 | $839.00K derived: sum of 3 quarters · filed 2022-05-09 | $1.67M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.25M derived: sum of 2 quarters · filed 2022-03-01 | $7.09M derived: sum of 3 quarters · filed 2022-03-01 | $4.81M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.29M derived: sum of 2 quarters · filed 2021-11-09 | $15.00K 10-Q · filed 2021-11-09 | $1.68M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $834.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$1.44M 10-Q · filed 2021-08-10 | $224.00K derived: sum of 3 quarters · filed 2022-03-01 | $940.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$2.28M 10-Q · filed 2021-05-10 | -$610.00K derived: sum of 2 quarters · filed 2022-03-01 | $106.00K derived: sum of 3 quarters · filed 2022-03-01 | -$706.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.38M derived: sum of 2 quarters · filed 2022-03-01 | $1.57M derived: sum of 3 quarters · filed 2022-03-01 | $3.15M 10-K · filed 2022-03-01 |
| 2019-09-30 | $716.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$96.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.49M 10-Q · filed 2020-11-09 | $1.13M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$812.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $773.00K 10-Q · filed 2020-08-10 | $413.00K derived: sum of 3 quarters · filed 2021-03-01 | $513.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.58M 10-Q · filed 2020-05-08 | $1.23M derived: sum of 2 quarters · filed 2021-03-01 | $1.32M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$260.00K derived: sum of 2 quarters · filed 2021-03-01 | $578.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $938.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $838.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |